α-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling path...

por Mason, Julie K., Klaire, Sukhpreet, Kharotia, Shikhil, Wiggins, Ashleigh K A, Thompson, Lilian U.
Publicado 2015